AVISTA Weightloss Center

AVISTA Weightloss Center in Gilbert, Arizona has specialized in medical weight management since 2011, operating under the clinical direction of Dr. Punya Raman, a physician holding dual board certifications in Family Medicine and Bariatric Medicine. This dual certification allows Dr. Raman to address weight loss within the broader context of metabolic health, hormone balance, and chronic disease prevention. The clinic serves patients throughout the East Valley, including Gilbert, Mesa, and Chandler, offering both in-office consultations and telehealth appointments for established patients managing ongoing treatment protocols. AVISTA distinguishes itself through physician-supervised programs that integrate pharmaceutical interventions with metabolic testing, nutritional counseling, and accountability structures designed for sustainable outcomes rather than temporary results.

The clinic's pharmaceutical weight loss protocols center on GLP-1 receptor agonists, specifically semaglutide and tirzepatide, which are prescribed following comprehensive metabolic assessment and cardiovascular screening. Semaglutide, the active ingredient in medications like Ozempic and Wegovy, works by mimicking the incretin hormone GLP-1 to regulate appetite and insulin secretion, while tirzepatide adds GIP receptor activation for dual incretin effect. Dr. Raman titrates these medications individually based on patient response, tolerance, and weight loss velocity, adjusting dosing protocols every four weeks during the initial treatment phase. AVISTA works with a contracted compounding pharmacy partner to provide these peptide therapies, ensuring consistent supply and competitive pricing for patients committed to multi-month treatment courses. The clinic does not offer these medications as standalone prescriptions; all patients receiving semaglutide or tirzepatide participate in the structured AVISTA program that includes regular weigh-ins, body composition analysis, and dietary modification support.

Dr. Raman's approach to bariatric medicine extends beyond peptide prescribing to include hormone optimization when metabolic testing reveals deficiencies that impair weight loss. The clinic offers bioidentical hormone replacement therapy for patients with documented thyroid dysfunction, testosterone deficiency, or estrogen imbalance that contributes to weight gain or prevents fat loss despite caloric restriction. AVISTA also provides allergy testing and treatment, recognizing that chronic inflammation from undiagnosed food sensitivities or environmental allergies can drive cortisol elevation and insulin resistance. As a board-certified family medicine physician, Dr. Raman serves as primary care provider for many weight loss patients, managing comorbid conditions such as type 2 diabetes, hypertension, and dyslipidemia concurrently with weight reduction efforts. This integrated model allows for real-time medication adjustments as patients lose weight and metabolic parameters improve, often reducing or eliminating the need for diabetes and blood pressure medications.

Patients beginning treatment at AVISTA Weightloss Center in Gilbert undergo an initial consultation that includes medical history review, current medication assessment, weight loss history discussion, and goal setting based on realistic timelines. Dr. Raman calculates body mass index, reviews any previous bariatric interventions or weight loss attempts, and orders baseline laboratory work including comprehensive metabolic panel, lipid panel, hemoglobin A1c, thyroid function tests, and hormone levels when clinically indicated. The clinic does not require patients to attempt diet and exercise alone before prescribing GLP-1 medications, but does establish that candidates understand the commitment required for weekly injections, potential gastrointestinal side effects during dose escalation, and the necessity of protein intake maintenance to preserve lean muscle mass during rapid weight loss. Follow-up visits occur every four weeks during active weight loss, then transition to every eight to twelve weeks during maintenance phase. The clinic's hybrid model allows established patients to conduct some follow-ups via telehealth, submitting weight and measurements remotely while discussing any side effects or plateau issues with Dr. Raman or clinical staff.

AVISTA's 4.9-star rating across 21 Google reviews reflects consistent patient feedback regarding the clinic's structured approach, the clarity of treatment plans, and the staff's responsiveness to questions throughout the weight loss process. Patients in Gilbert seeking medical weight loss have access to a physician with specific bariatric certification rather than a general practitioner offering weight loss as an ancillary service. The clinic's longevity since 2011 demonstrates sustained expertise in an evolving field, with Dr. Raman incorporating newer agents like tirzepatide as clinical evidence supports their use. AVISTA does not accept insurance for weight loss services, operating on a fee-for-service model that includes medication costs, office visits, and program support as a bundled monthly fee. This structure provides cost transparency and eliminates prior authorization delays common with insurance-based weight loss treatment, allowing patients to begin semaglutide or tirzepatide therapy immediately following medical clearance.